Search the Newsreel

Barclays Adjusts AbbVie PT to $300 From $275, Maintains Overweight Rating

Barclays has increased its price target for AbbVie (ABBV) to $300 from $275, while reiterating an Overweight rating on the stock. The adjustment reflects an updated outlook from the analytical firm regarding the pharmaceutical company's future performance. AbbVie specializes in therapeutic drug research and …

Goldman Sachs uncovers key AbbVie stock signals before earnings

BrightView (BV) Projected to Announce Quarterly Earnings on Tuesday

BBVA Banco Frances S.A. (NYSE:BBAR) Given Consensus Rating of "Moderate Buy" by Brokerages

ABVC Biopharma Inc (ABVC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of ABVC Biopharma Inc's (ABVC) dividend history and stock split events. It indicates that the company has not distributed any dividends in the past five years and lists several merger-related stock splits that occurred on July 24, 2023, each …

ABVC Biopharma Inc (ABVC) Cash Flow

This article provides a detailed cash flow statement for ABVC Biopharma Inc (ABVC), encompassing quarterly and annual data for operating, investing, and financing activities. It also includes frequently asked questions explaining different types of cash flow and their significance for the company's financial health. …

New Century Logistics (BVI) Limited Revenue Breakdown – NASDAQ:NCEW

ABVC Biopharma Inc (ABVC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for ABVC Biopharma Inc (ABVC), detailing its business segments, regional revenue, and profit contribution. However, the data has not been disclosed by the company yet, indicating a lack of publicly available information on these specific financial …

Eli Lilly (NYSE: LLY) reports 21.99M-share beneficial stake in ProQR Therapeutics

Eli Lilly and Company has reported a beneficial ownership of 21,995,880 ordinary shares in ProQR Therapeutics N.V., representing a 15.6% stake. This information was disclosed in an amended Schedule 13G/A filing, indicating that Eli Lilly holds sole voting and dispositive power over all these …

ABVC Biopharma Inc (ABVC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of ABVC Biopharma Inc (ABVC), noting its current stock price momentum score is 5.98, ranking 29th in its industry. The stock is trading between a resistance level of 1.79 and a support level of 0.60, suggesting suitability for …

BV Financial Inc (BVFL) Income Statement

This article presents the income statement for BV Financial Inc (BVFL), offering both quarterly and annual financial insights. It details key metrics such as total revenue, operating expenses, operating profit, income before tax, income tax, income after tax, net income attributable to controlling interests …

Brightview Holdings Inc (BV) Income Statement

This article provides a detailed quarterly and annual income statement for Brightview Holdings Inc (BV), offering insights into its financial performance and operational efficiency. It presents key financial metrics such as total revenue, cost of revenue, operating expenses, operating profit, net income, and earnings …

ABVC Biopharma Inc (ABVC) Institutional Confidence

The article analyzes the institutional confidence in ABVC Biopharma Inc (ABVC), noting its current institutional shareholding score of 3.00, placing it 192nd in its industry. Institutional ownership stands at 3.41%, an increase of 1.88% quarter-over-quarter. James Simons is identified as the largest institutional shareholder, …

BV Financial Inc (BVFL) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides dividend and stock split information for BV Financial Inc (BVFL). It indicates that BVFL has distributed $0.00 in dividends over the past five years and currently shows no dividend data available. The page also displays current stock metrics such as market …

Pharvaris NV (PHVS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Pharvaris NV (PHVS), listing major shareholders like General Atlantic LLC and Fidelity Management & Research Company LLC. It breaks down shareholder types, including private equity and hedge funds, and provides a quarterly overview of institutional shareholdings and …

Brightview Holdings Inc (BV) Cash Flow

This article presents the quarterly and annual cash flow statements for Brightview Holdings Inc (BV), covering operating, investing, and financing activities. It provides detailed financial data from FY2018Q1 to FY2026Q2 for various cash flow components, including net income, operating gains/losses, capital expenditures, and debt …

Dbv Technologies SA (DBVT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for Dbv Technologies SA (DBVT), including stock price information and market capitalization. However, it explicitly states that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. Consequently, …

Sarepta taps AbbVie, Tessera vet Severino to write Duchenne firm's next chapter

Sarepta Therapeutics has appointed Michael Severino, former vice chairman at AbbVie and CEO of Tessera Therapeutics, as its new chief executive, effective Tuesday. Severino replaces Doug Ingram, who is retiring due to family health issues. Severino will face the challenge of navigating commercial realities …

Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO

Sarepta Therapeutics has appointed Michael Severino, an executive with experience at AbbVie and Amgen and most recently Tessera Therapeutics, as its new CEO, effective July 28. Severino faces the challenge of turning around Sarepta's fortunes, as the company has lost significant market value over …

Pharvaris NV (PHVS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses the revenue breakdown for Pharvaris NV (PHVS), indicating that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. Despite providing a stock overview with current trading figures and market cap, specific financial …

Sarepta names former AbbVie R&D exec Michael Severino as next CEO

Sarepta Therapeutics has appointed Michael Severino, formerly of Tessera Therapeutics and AbbVie, as its new CEO, succeeding Doug Ingram. Severino takes the helm at a critical juncture as Sarepta awaits two key FDA decisions for its Duchenne muscular dystrophy drugs, Amondys 45 and Vyondys …

AbbVie stock hits all-time high of 261.71 USD

AbbVie Inc. (ABBV) stock has reached a new all-time high of $261.71, reflecting a 40.53% total return over the past year. Despite being considered slightly overvalued by InvestingPro analysis, the company demonstrates strong financial health with 9.5% revenue growth. Upcoming earnings on July 31st …

Is AbbVie Stock a Buy After Its $10.9 Billion Apogee Bet

AbbVie (ABBV) recently acquired Apogee Therapeutics for $10.9 billion, a move that is expected to dilute adjusted EPS until 2032 but aims for a "mega blockbuster" drug, zumilokibart, targeting over $10 billion in peak sales. Despite the near-term dilution, AbbVie stock has largely recovered …

Sarepta names former Abbvie president as CEO as Ingram retires

Sarepta Therapeutics has appointed Michael Severino, former Tessera Therapeutics CEO and a longtime AbbVie executive, as its new chief executive, effective July 28. Severino will succeed Doug Ingram, who is stepping down after leading Sarepta since 2017 but will remain in an advisory role …

New Century Logistics (BVI) Ltd (NCEW) Cash Flow

This article provides an overview of New Century Logistics (BVI) Ltd's (NCEW) cash flow statements, including operating, investing, and financing cash flows, along with definitions for each. It highlights key financial figures for the company, such as a -3.42M operating cash flow in fiscal …

Banco Bbva Argentina SA (BBAR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Banco Bbva Argentina SA (BBAR), listing its major shareholders and institutional holdings as of recent reporting periods. It identifies top individual shareholders like Fourth Sail Capital LP and PointState Capital LP, categorizes shareholder types, and provides a …

How Abbvie Inc. (ABBV) Affects Rotational Strategy Timing

This article from Stock Traders Daily analyzes Abbvie Inc. (ABBV) and its impact on rotational strategy timing. It highlights a neutral sentiment for ABBV across all horizons, suggesting a wait-and-see approach, and identifies no resistance levels above the current price, indicating potential upside. The …

DBV Technologies (Nasdaq: DBVT) sets up broad shelf to issue shares, ADSs and warrants

DBV Technologies (Nasdaq: DBVT) has filed an automatic shelf registration statement on Form S-3, allowing it to issue an indeterminate amount of ordinary shares, ADSs, and warrants. This permits the company and selling security holders to conduct offerings flexibly, with net proceeds from DBV's …

Pharvaris NV (PHVS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Pharvaris NV (PHVS) regarding its dividend history and stock splits. It states that the company has not distributed any dividends over the past five years and contains no data on dividend dates. The article includes current stock trading …

ABVC Biopharma Inc (ABVC) Balance Sheet

This article provides the comprehensive balance sheet for ABVC Biopharma Inc (ABVC), presenting both quarterly and annual financial data. It details assets, liabilities, and shareholders' equity over multiple fiscal years, allowing users to analyze the company's financial health, liquidity, leverage, and return on equity. …

Brightview Holdings Inc (BV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Brightview Holdings Inc (BV), detailing contributions from its "Landscape Maintenance," "Development Services," and "Snow Removal" business segments. The financial data is presented in USD and shows the proportion of revenue each segment contributes, along with an "Eliminations" …

New Century Logistics (BVI) Ltd (NCEW) Income Statement

This article provides an income statement for New Century Logistics (BVI) Ltd (NCEW) through TradingKey.com, offering both quarterly and annual financial data. It explains how to interpret the income statement, defines key metrics like YOY, and presents NCEW's revenue, net income, and operating profit …

BV Financial Inc - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

This article provides a detailed profile of BV Financial Inc (BVFL), the parent company of BayVanguard Bank. It covers the company's background, business scope as a community-oriented financial institution in Baltimore, Maryland, and its financial services. The profile also lists key financial data, market …

Brightview Holdings Inc (BV) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article from TradingKey provides a dividend and stock split history for Brightview Holdings Inc (BV). It states that no dividends have been distributed by the company over the past five years. The page displays current stock metrics such as market cap and P/E …

ABVC Biopharma Inc (ABVC) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of ABVC Biopharma Inc (ABVC), noting its current valuation score is 7.27, ranking 241 out of 386 in its industry. It highlights the company's P/E ratio of -2.56, but points out that key data for P/B, P/S, and …

ABVC Biopharma Inc (ABVC) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides details on the shareholder structure of ABVC Biopharma Inc (ABVC), outlining the major individual and corporate shareholders, as well as institutional holdings. It lists the proportion of shares held by key entities like Jiang (Shuling) and YuanGene, Corp, along with data …